Avian flu vaccines: France chooses a German laboratory

Published 2023년 7월 12일

Tridge summary

France has chosen Boehringer Ingelheim, a German laboratory, to provide up to 80 million doses of avian flu vaccine for ducks starting in October. The vaccination campaign aims to reduce viral excretion, slow down transmission, and control the risk to human health. Boehringer Ingelheim was chosen because it can meet the needs of vaccinating both mule ducks and Muscovy ducks, and if the decision is made to vaccinate all year round, a new order of vaccines will be placed.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Faced with avian flu, France has chosen a German laboratory, Boehringer Ingelheim, to provide it with up to 80 million doses to vaccinate ducks in the fall. The vaccination campaign, eagerly awaited by breeders, should start in October, according to the Ministry of Agriculture, for a period of six months. Each duck will receive two doses. The avian influenza virus epizootic, which rages in America, Europe and Asia, has led to the euthanasia of tens of millions of poultry in France in recent years. To combat this highly pathogenic virus, "vaccination of the most receptive and susceptible poultry aims to reduce viral excretion to slow down transmission, but also to reduce the statistical risk of virus mutation, limit the number of people exposed and thus controlling the risk to human health”, recently underlined the Committee for monitoring and anticipating health risks (Covars) in an opinion. 17,500 turkeys slaughtered in early July in France For this, the government published in ...
Source: Lefigaro

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.